Home > Insider Trading > Filing (0001209191-15-007474)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142596	Nuvasive Inc	NUVA	Surgical & Medical Instruments & Apparatus (3841)	330768598

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1289408	Keith Valentine	7475 Lusk Blvd. San Diego CA 92121	Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-01-27	65,577	$38.94	154,511	No	4	M	Direct
Common Stock	Disposition	2015-01-27	58,607	$46.93	95,904	No	4	F	Direct
Common Stock	Disposition	2015-01-28	6,970	$46.96	88,934	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2015-01-27	65,577	$0.00	65,577	$38.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2018-01-04	No	4	M	Direct

Footnotes

Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on December 12, 2014, which is intended to comply with Rule 10b5-1.
Weighted average from 45 transactions with prices ranging from $46.4100 to $47.3200. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
The option, representing a right to purchase a total of 196,729 shares, became exercisable as follows: 25% of the shares vested on January 4, 2009; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 4, 2012, subject to continued employment through each vesting period.